Done deal: Johnson & Johnson and 3 distributors agree to historic $26 billion opioid settlement kdunleavy Wed, 07/21/2021 – 16:38 More: Done deal: Johnson & Johnson and 3 distributors agree to historic billion opioid settlement Source: fierce
read moreJohnson & Johnson eyes $2.5B in COVID vaccine sales as key immunology, oncology meds trounce expectations fkansteiner Wed, 07/21/2021 – 11:20 More: Johnson & Johnson eyes .5B in COVID vaccine sales as key immunology, oncology meds trounce expectations Source: fierce
read moreAstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases nhigginsdunn Wed, 07/21/2021 – 11:05 More: AstraZeneca closes mega B Alexion buyout despite antitrust fears, making a splash in rare diseases Source: fierce
read moreWith Biovac agreement, Pfizer and BioNTech extend their COVID-19 vaccine manufacturing network to Africa kdunleavy Wed, 07/21/2021 – 10:43 More: With Biovac agreement, Pfizer and BioNTech extend their COVID-19 vaccine manufacturing network to Africa Source: fierce
read moreIs Entresto maker Novartis scared of Jardiance’s landmark heart failure win? Not really, exec says aliu Wed, 07/21/2021 – 10:34 More: Is Entresto maker Novartis scared of Jardiance's landmark heart failure win? Not really, exec says Source: fierce
read moreEC has cleared Ryeqo for the treatment of moderate to severe symptoms of uterine fibroids More: Myovant, Gedeon Richter’s uterine fibroids med Ryeqo bags EU approval Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals